Gland Pharma

Laurus Labs, Divis: Why pharma stocks are rising today

Dec 19, 2025, 12:19 PM IST

Pharma stock Laurus Labs advanced 2.42 per cent to Rs 1,039.70. Divis Laboratories Ltd gained 1.87 per cent to Rs 6500.10. Gland Pharma added 0.34 per cent to Rs 1,671.55.

Trump tariff impact: Gland Pharma, Zydus, Aurobindo shares fall up to 4%; analyst views

Sep 26, 2025, 09:22 AM IST

Gland Pharma dropped 4.03 per cent to open at Rs 1,892.50. Zydus Life fell 3.54 per cent to open at Rs 990.55. Natco Pharma slipped 2.7 per cent, Aurobindo Pharma declined 2.45 per cent

Top stocks in news: NSDL, Bharti Airtel, Sri Lotus, Britannia, Lupin, M&B, PB Fintech

Aug 06, 2025, 07:57 AM IST

Stocks including NSDL, Bharti Airtel, Sri Lotus Developers, Britannia Industries, Lupin, M&B Engineering, PB Fintech and more will be in the spotlight on Wednesday, August 06.

Gland Pharma share price target at Rs 2,340: MOFSL sees 19% upside, retains Buy

Aug 06, 2025, 08:27 AM IST

MOFSL has increased its earnings estimates for Gland Pharma by 9% for FY26 and 3% for FY27, citing the scale-up of GLP-1 products and potential launches in the US and EU markets.

Top stocks in news: DMart, Adani Green, RITES, HCL Tech, IRB Infra, NCC, Wockhardt, BEML

Jul 14, 2025, 08:01 AM IST

Stocks including Avenue Supermarts, Adani Green Energy, RITES, HCL Tech, IRB Infra, NCC, Wockhardt, BEML, Indegene, HFCL and more will be in the spotlight on Monday, July 14.

Top stocks in news: YES Bank, BEL, Vedanta, HAL, Gland Pharma, NTPC Green, Newgen Software

Jun 05, 2025, 08:30 AM IST

Stocks including YES Bank, Bharat Electronics, Hindustan Aeronautics, Gland Pharma, NTPC Green Energy and more will be in the spotlight on Thursday, June 05.

'Battling on multiple fronts': Gland Pharma shares up 5% despite subdued Q4; here's target price

May 21, 2025, 12:13 PM IST

Gland Pharma's Q4 results were in line with Kotak's estimates but fell short of consensus due to a drop in base business sales. The company plans significant investment in Cenexi, anticipating mid-teens topline growth in FY2026. Kotak maintains a REDUCE rating with a fair value of Rs1,500.

Top stocks to watch: SBI, KPR Mills, ONGC, Gland Pharma, IRCON, Dixon Tech, United Spirits

May 21, 2025, 07:44 AM IST

Stocks including State Bank of India, KPR Mills, ONGC, Gland Pharma, IRCON, Dixon Technologies, United Spirits, NHPC, Torrent Pharma and more will be in the spotlight on Wednesday, May 21.

Pharma stocks: Sun Pharma, Aurobindo, Gland, DRL in focus after Trump tariff warning

Apr 15, 2025, 09:05 AM IST

Aurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and 20-23 per cent in 2025 so far. Glenmark Pharma is down 10 per cent for the week month period and 14.45 per cent year-to-date.

Aurobindo, Sun Pharma, other pharma stocks in focus after 90-day Trump tariff pause

Apr 10, 2025, 10:02 AM IST

Aurobindo Pharma and Gland Pharma have fallen 9 per cent each in the past one week and 22-23 per cent in 2025 so far. Glenmark Pharma is down 9 per cent for the week month period and 14 per cent year-to-date.

Pharma stocks crack up to 10% as Trump warns of 'never seen before' tariffs

Apr 04, 2025, 12:01 PM IST

Granules India, Lupin, Gland Pharma and Cipla fell 5-6 per cent. Sun Pharmaceutical Industries slipped 5 per cent while Dr Reddy's Labs was down 4 per cent.